Second Messengers: Definition, Mechanisms, and Roles in Cell Signaling

By Dr. Zubair Khalid, DVM, MS, PhD ·

Second Messengers: Definition, Mechanisms, and Roles in Cell Signaling

Introduction to Second Messengers

Definition and Basic Concept

A second messenger is a small intracellular signaling molecule that is produced or released in response to an extracellular stimulus (the "first messenger," typically a hormone, neurotransmitter, or growth factor) and propagates the signal inside the cell by binding to and modulating specific effector proteins. The term "second messenger" was coined to distinguish these intracellular molecules from the extracellular signals that initiate the cascade.

Second messengers are central to the process of Signal Transduction, the mechanism by which cells convert extracellular cues into specific intracellular responses. Unlike the first messenger, which never enters the cell, second messengers are generated within the cytoplasm or membrane and diffuse to their targets, often triggering a cascade of downstream events. Their small size and rapid production allow them to act quickly, while their enzymatic degradation ensures that the signal is transient and tightly controlled.

The defining features of a second messenger are: (1) its concentration increases in response to an extracellular stimulus, (2) it binds to specific intracellular targets with high affinity, and (3) its removal or degradation terminates the cellular response. These molecules include cyclic nucleotides, lipid-derived messengers, calcium ions, and gaseous molecules.

Historical Context and Discovery

The concept of second messengers emerged from the pioneering work of Earl Sutherland in the late 1950s. Studying glycogen breakdown in liver cells, Sutherland discovered that the hormone epinephrine (adrenaline) stimulated glycogenolysis without entering the cell. Instead, epinephrine bound to a receptor on the cell surface, leading to the production of a heat-stable, small molecule within the cell that could activate glycogen phosphorylase. This molecule was identified as cyclic adenosine monophosphate (cAMP), and Sutherland's work earned him the Nobel Prize in Physiology or Medicine in 1971.

Subsequent decades expanded the field dramatically. In the 1970s, cyclic guanosine monophosphate (cGMP) was characterized, and the role of calcium ions as a universal second messenger became firmly established. The 1980s saw the discovery of inositol trisphosphate (IP3) and diacylglycerol (DAG) as products of phospholipase C activity, and nitric oxide (NO) was identified as a gaseous second messenger in the 1990s. Today, the second messenger concept encompasses a diverse array of molecules that coordinate nearly every aspect of cellular physiology.

The Need for Second Messengers

Signal Amplification

One of the most critical reasons cells employ second messengers is signal amplification. A single extracellular ligand molecule binding to a receptor can lead to the production of thousands of second messenger molecules. For example, one molecule of epinephrine binding to a β-adrenergic receptor activates a single adenylyl cyclase enzyme via a G protein, but that enzyme can catalyze the synthesis of many cAMP molecules per second. Each cAMP molecule then activates a Protein Kinase, which can phosphorylate multiple substrate proteins, each of which can catalyze further reactions. This cascade produces an amplification factor of 10⁶ to 10⁸, meaning a single hormone molecule can ultimately generate a massive cellular response.

This amplification is essential because extracellular signals are often present at very low concentrations (nanomolar to picomolar). Without amplification, the cell would be unable to mount a sufficient response. The cascade architecture also allows for multiple points of regulation, enabling the cell to fine-tune the magnitude and duration of the response.

Spatial and Temporal Regulation

Second messengers provide spatial and temporal control that direct receptor signaling alone cannot achieve. Because second messengers diffuse within the cell, they can act locally or globally depending on their production rate, diffusion coefficient, and degradation kinetics. For instance, calcium ions can produce highly localized "sparks" and "puffs" near the site of release, or they can generate global waves that sweep across the entire cell. This spatial heterogeneity allows a single cell to respond differently in distinct subcellular regions.

Temporal regulation is equally important. The duration of a second messenger signal—whether it is a transient spike lasting milliseconds or a sustained elevation lasting minutes—encodes information that determines the cellular outcome. For example, in neurons, the frequency of calcium oscillations can selectively activate different transcription factors: high-frequency oscillations activate NF-κB, while lower frequencies preferentially activate NFAT (nuclear factor of activated T-cells). This frequency-encoded signaling allows a single second messenger to control diverse gene expression programs.

Major Classes of Second Messengers

Cyclic Nucleotides

Cyclic AMP (cAMP) is the prototypical second messenger. It is synthesized from ATP by adenylyl cyclase and degraded to AMP by phosphodiesterases. cAMP activates protein kinase A (PKA), which phosphorylates serine and threonine residues on target proteins. cAMP also directly regulates cyclic nucleotide-gated ion channels and the exchange protein directly activated by cAMP (EPAC), a guanine nucleotide exchange factor for the small GTPase Rap1.

Cyclic GMP (cGMP) is synthesized from GTP by guanylyl cyclase, which exists in both soluble (cytosolic) and particulate (membrane-bound) forms. Soluble guanylyl cyclase is activated by nitric oxide, while particulate guanylyl cyclases are receptors for natriuretic peptides. cGMP activates protein kinase G (PKG), regulates cyclic nucleotide-gated channels, and modulates phosphodiesterase activity. In the retina, cGMP directly opens cyclic nucleotide-gated channels, maintaining the dark current in photoreceptor cells.

Lipid-Derived Messengers

Diacylglycerol (DAG) and inositol trisphosphate (IP3) are produced by phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2). DAG remains embedded in the plasma membrane and recruits and activates protein kinase C (PKC), which translocates from the cytosol to the membrane upon activation. IP3 is water-soluble and diffuses into the cytoplasm, where it binds to IP3 receptors on the endoplasmic reticulum, triggering calcium release.

Phosphatidylinositol 3,4,5-trisphosphate (PIP3) is generated by phosphoinositide 3-kinase (PI3K) phosphorylation of PIP2. PIP3 recruits proteins containing pleckstrin homology (PH) domains to the plasma membrane, most notably AKT (protein kinase B). This pathway is central to cell survival, growth, and metabolism, and is frequently dysregulated in cancer. The PI3K AKT Pathway is a major target for therapeutic intervention.

Calcium Ions

Calcium (Ca²⁺) is arguably the most versatile second messenger. The resting cytosolic calcium concentration is maintained at approximately 100 nM, while the extracellular concentration is around 1–2 mM and the endoplasmic reticulum lumen contains roughly 0.5–1 mM. This steep electrochemical gradient allows rapid, large-magnitude calcium signals to be generated by opening calcium channels.

Calcium signals are generated by two main routes: influx from the extracellular space through plasma membrane calcium channels (voltage-gated, ligand-gated, or store-operated), and release from intracellular stores (primarily the endoplasmic reticulum) through IP3 receptors and ryanodine receptors. Calcium exerts its effects by binding to calcium-binding proteins, most notably calmodulin (CaM). The calcium-calmodulin complex activates numerous enzymes, including calcium/calmodulin-dependent protein kinases (CaMKs) and calcineurin, a protein phosphatase. Calcium also directly regulates many ion channels, cytoskeletal proteins, and the contractile apparatus in muscle.

Gaseous Messengers

Nitric oxide (NO) is a unique gaseous second messenger that diffuses freely across membranes. It is synthesized from L-arginine by nitric oxide synthase (NOS), which exists in three isoforms: neuronal (nNOS), inducible (iNOS), and endothelial (eNOS). NO activates soluble guanylyl cyclase, increasing cGMP production. In the cardiovascular system, NO released from endothelial cells causes vasodilation of smooth muscle, a mechanism exploited by nitroglycerin in treating angina.

Carbon monoxide (CO) and hydrogen sulfide (H₂S) are additional gaseous messengers. CO is produced by heme oxygenase and, like NO, can activate soluble guanylyl cyclase, albeit with lower potency. H₂S is generated by cystathionine β-synthase and cystathionine γ-lyase and modulates ion channels and transcription factors. These gases are increasingly recognized as important regulators of inflammation, neurotransmission, and vascular tone.

Mechanisms of Second Messenger Generation and Degradation

Synthesis by Enzymes

The synthesis of second messengers is catalyzed by specific enzymes that are tightly regulated by upstream signals. Adenylyl cyclase (AC) catalyzes the conversion of ATP to cAMP and pyrophosphate. There are ten mammalian AC isoforms, nine of which are transmembrane proteins activated by Gαs subunits and inhibited by Gαi subunits. The tenth isoform, soluble AC, is activated by bicarbonate and calcium, linking cAMP production to metabolic state.

Guanylyl cyclase exists in two forms: soluble (sGC), which is a heterodimer activated by NO binding to its heme group, and particulate (pGC), which is a single-pass transmembrane receptor with extracellular ligand-binding domains for natriuretic peptides.

Phospholipase C (PLC) hydrolyzes PIP2 to generate DAG and IP3. There are six families of PLC isoforms (β, γ, δ, ε, ζ, η). PLCβ is activated by Gαq subunits and Gβγ subunits, while PLCγ is activated by tyrosine kinase phosphorylation downstream of Receptor Tyrosine Kinase activation. This distinction allows different extracellular signals to converge on the same second messenger pathway through different receptor classes.

Phosphoinositide 3-kinase (PI3K) phosphorylates PIP2 at the 3-position of the inositol ring to generate PIP3. Class I PI3Ks are heterodimers consisting of a catalytic subunit (p110) and a regulatory subunit (p85). PI3K is activated by receptor tyrosine kinases, G protein-coupled receptors, and Ras.

Calcium is not synthesized but released from stores. IP3 receptors (IP3Rs) and ryanodine receptors (RyRs) are large tetrameric calcium channels on the endoplasmic reticulum. IP3 binding to IP3Rs increases their open probability, but calcium itself modulates channel activity in a biphasic manner: low calcium enhances opening, while high calcium inhibits it. This property underlies calcium-induced calcium release and the generation of calcium waves and oscillations.

Degradation and Inactivation

Signal termination is as important as signal generation. Cyclic nucleotides are degraded by phosphodiesterases (PDEs), a superfamily of enzymes with 11 families (PDE1–PDE11). PDE4 is cAMP-specific, PDE5 is cGMP-specific, and PDE1 and PDE2 are dual-specificity enzymes regulated by calcium-calmodulin and cGMP, respectively. PDE inhibitors, such as caffeine (non-selective) and sildenafil (PDE5-selective), are important pharmacological tools and therapeutic agents.

DAG is rapidly phosphorylated by diacylglycerol kinase to produce phosphatidic acid, which is recycled into phospholipid synthesis. IP3 is sequentially dephosphorylated by inositol phosphatases, ultimately yielding free inositol that is reincorporated into phosphatidylinositol. Lithium inhibits inositol monophosphatase, which depletes IP3 precursors—a mechanism relevant to its therapeutic action in bipolar disorder.

Calcium is removed from the cytosol by several mechanisms: the plasma membrane calcium ATPase (PMCA) pumps calcium out of the cell, the sarco/endoplasmic reticulum calcium ATPase (SERCA) pumps calcium back into the ER, and the sodium-calcium exchanger (NCX) couples calcium efflux to sodium influx. Mitochondria also take up calcium via the uniporter, serving as a buffer and contributing to metabolic regulation.

Gaseous messengers are inactivated by diffusion away from their site of action and by chemical reactions. NO has a half-life of only a few seconds in biological systems, reacting with oxygen, superoxide, and hemoglobin. This short half-life restricts NO signaling to a paracrine mode, affecting only nearby cells.

Second Messenger Targets and Effector Proteins

Protein Kinases and Phosphatases

The most common mechanism by which second messengers exert their effects is through activation of protein kinases, which phosphorylate downstream substrates. cAMP activates PKA, a tetrameric holoenzyme consisting of two regulatory (R) subunits and two catalytic (C) subunits. cAMP binding to the R subunits causes dissociation and release of the active C subunits, which then phosphorylate cytoplasmic and nuclear targets. PKA phosphorylates a consensus sequence of Arg-Arg-X-Ser/Thr.

cGMP activates PKG, a homodimeric serine/threonine kinase that is particularly abundant in smooth muscle, platelets, and the cerebellum. PKG phosphorylates substrates involved in smooth muscle relaxation, including the inositol trisphosphate receptor-associated cGMP kinase substrate (IRAG) and the large conductance calcium-activated potassium channel.

Calcium, via calmodulin, activates CaMKs. CaMKII is particularly notable for its autophosphorylation, which renders the kinase partially active even after calcium levels return to baseline. This property gives CaMKII a "molecular memory" that is important for long-term potentiation in neurons and for cardiac contractility.

The balance between phosphorylation and dephosphorylation is maintained by protein phosphatases. Protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) are major serine/threonine phosphatases that reverse the actions of PKA, PKG, and CaMKs. Calcineurin (protein phosphatase 2B) is specifically activated by calcium-calmodulin and dephosphorylates NFAT transcription factors, allowing their nuclear translocation.

Ion Channels and Other Effectors

Second messengers directly regulate ion channels, providing rapid electrical and ionic responses. Cyclic nucleotide-gated (CNG) channels are directly opened by cAMP or cGMP binding. These channels are essential for olfactory and visual transduction. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which generate the pacemaker current in cardiac and neuronal cells, are modulated by cAMP binding that shifts their voltage dependence.

Calcium directly gates several ion channels, including calcium-activated potassium channels (SK and BK channels) and calcium-activated chloride channels. Calcium also regulates the ryanodine receptor, which is itself a calcium channel, enabling calcium-induced calcium release.

Beyond kinases and channels, second messengers bind to a variety of other effectors. EPAC (exchange protein directly activated by cAMP) is a guanine nucleotide exchange factor that activates Rap1, a small GTPase involved in cell adhesion and proliferation. IP3 receptors are both channels and receptors, and the IP3R itself is a target for regulation by ATP, calcium, and phosphorylation. PIP3 recruits proteins to the membrane via PH domains, including AKT and its activator PDK1, as well as BTK (Bruton's tyrosine kinase) and GRP1 (general receptor for phosphoinositides).

Physiological Roles of Second Messengers

cAMP in Glycogen Metabolism

The classic example of second messenger function is cAMP's role in glycogen metabolism. When epinephrine binds to β-adrenergic receptors on hepatocytes, the activated Gαs subunit stimulates adenylyl cyclase, increasing cAMP levels. cAMP activates PKA, which phosphorylates and activates phosphorylase kinase. Phosphorylase kinase then phosphorylates and activates glycogen phosphorylase, the enzyme that catalyzes glycogen breakdown. Simultaneously, PKA phosphorylates and inactivates glycogen synthase, shutting off glycogen synthesis. This coordinated regulation ensures that glucose is rapidly mobilized from glycogen stores in response to the "fight-or-flight" hormone.

The pathway is terminated by multiple mechanisms: phosphodiesterases degrade cAMP, G protein-coupled receptor kinases (GRKs) phosphorylate the receptor leading to β-arrestin binding and desensitization, and protein phosphatases reverse the phosphorylations. This multilayered regulation prevents excessive or prolonged glycogenolysis.

Calcium in Muscle Contraction

In skeletal and cardiac muscle, calcium is the direct trigger for contraction. An action potential depolarizes the plasma membrane and T-tubules, activating voltage-gated L-type calcium channels (dihydropyridine receptors). In skeletal muscle, the L-type channel physically interacts with the ryanodine receptor (RyR1) on the sarcoplasmic reticulum, causing calcium release. In cardiac muscle, calcium influx through L-type channels triggers calcium-induced calcium release from RyR2.

The released calcium binds to troponin C, causing a conformational change in the troponin-tropomyosin complex that exposes myosin-binding sites on actin filaments. Myosin heads then bind actin, undergo the power stroke, and generate force. Relaxation occurs when SERCA pumps calcium back into the sarcoplasmic reticulum, lowering cytosolic calcium and allowing tropomyosin to again block myosin binding.

DAG and IP3 in Cell Proliferation

Many growth factors and mitogens activate PLCγ downstream of receptor tyrosine kinases, generating DAG and IP3. DAG activates PKC, which phosphorylates substrates involved in cell cycle progression, including the Raf kinase and various transcription factors. IP3 releases calcium, which activates calcium-dependent transcription factors and CaMKs.

The calcium and PKC pathways converge on the activation of immediate early genes such as c-Fos and c-Jun, which form the AP-1 transcription factor complex. AP-1 drives expression of cyclin D1, a regulatory subunit of Cyclin Dependent Kinase 4 and 6, promoting G1-to-S phase transition. Dysregulation of this pathway, particularly through constitutive PLCγ activation or PKC overexpression, contributes to uncontrolled proliferation in many cancers.

Methods to Study Second Messengers

Biosensors and Imaging

Genetically encoded fluorescent biosensors have revolutionized the study of second messengers. The most widely used calcium indicators are the GCaMP family, which consist of a circularly permuted green fluorescent protein (cpGFP) fused to calmodulin and the M13 peptide from myosin light chain kinase. Calcium binding causes a conformational change that increases fluorescence intensity. GCaMP6 variants have response kinetics fast enough to detect individual action potentials in neurons.

FRET (Förster resonance energy transfer)-based biosensors are used for cAMP and cGMP. These sensors typically consist of a cAMP-binding domain (such as EPAC) or cGMP-binding domain (such as PKG) sandwiched between two fluorescent proteins, CFP and YFP. Second messenger binding induces a conformational change that alters FRET efficiency, allowing ratiometric measurement. The Epac1-camps sensor and the cGES-DE5 sensor are commonly used examples.

For lipid messengers, the translocation of PH domain-containing proteins fused to GFP is used. For example, the PH domain of PLCδ1 fused to GFP (PH-PLCδ1-GFP) translocates from the plasma membrane to the cytosol upon PIP2 hydrolysis, providing a readout of PLC activity. Similarly, the PH domain of AKT (PH-AKT-GFP) translocates to the membrane upon PIP3 production.

Pharmacological Tools

Pharmacological inhibitors and activators are essential for dissecting second messenger pathways. Forskolin directly activates adenylyl cyclase, while isoproterenol activates β-adrenergic receptors. IBMX (3-isobutyl-1-methylxanthine) is a non-selective phosphodiesterase inhibitor that raises cAMP and cGMP levels. Rp-cAMPS is a competitive inhibitor of cAMP binding to PKA, while KT5720 is a PKA catalytic inhibitor.

For calcium signaling, thapsigargin inhibits SERCA, depleting ER calcium stores and activating store-operated calcium entry. Ionomycin is a calcium ionophore that increases cytosolic calcium independent of channels. BAPTA-AM is a cell-permeable calcium chelator that buffers cytosolic calcium increases.

For lipid signaling, U73122 inhibits PLC, while PMA (phorbol 12-myristate 13-acetate) is a DAG analog that directly activates PKC. Wortmannin and LY294002 are PI3K inhibitors, and rapamycin inhibits mTORC1, a downstream effector of the PI3K pathway.

Genetic Approaches

Genetic manipulation allows perturbation of second messenger pathways with precision. Knockout mice lacking specific adenylyl cyclase isoforms, phosphodiesterases, or calcium channels have revealed the physiological roles of these proteins. For example, mice lacking the type 5 adenylyl cyclase (AC5) are protected from cardiac stress, while PDE4D knockout mice show altered learning and memory.

RNA interference (siRNA and shRNA) and CRISPR-Cas9 gene editing allow targeted knockdown or knockout in cultured cells. Dominant-negative mutants, such as a kinase-dead PKA, and constitutively active mutants, such as a calcium-independent CaMKII, provide additional tools. Optogenetic approaches, such as channelrhodopsin for calcium influx and photoactivatable adenylyl cyclase (PAC) for cAMP production, enable precise spatial and temporal control of second messenger levels with light.

Common Pitfalls and Misconceptions

Second Messengers vs. Hormones

A frequent error is confusing second messengers with hormones or other first messengers. Hormones are extracellular signaling molecules that travel through the bloodstream to act on distant target cells. They never enter the cell; instead, they bind to cell-surface receptors. Second messengers are produced inside the cell in response to hormone-receptor binding. The relationship is hierarchical: a hormone (first messenger) triggers the production of a second messenger, which then propagates the signal. For example, insulin is a hormone, but PIP3 is a second messenger produced downstream of insulin receptor activation.

Solubility and Compartmentalization

Students often assume all second messengers are water-soluble and diffuse freely throughout the cytoplasm. This is incorrect. DAG and PIP3 are lipid-anchored and remain in the plasma membrane. Their actions are restricted to the membrane compartment, where they recruit and activate membrane-associated proteins. Even water-soluble messengers like cAMP and calcium are not uniformly distributed; they form microdomains of elevated concentration near their sites of production or release. The concept of compartmentalized signaling is critical for understanding how a single second messenger can produce different outcomes in different cellular locations.

Importance of Signal Termination

Another common misconception is that signal generation alone determines the cellular response. In reality, signal termination is equally important. The duration and amplitude of a second messenger signal are determined by the balance between synthesis and degradation. Persistent activation of a pathway due to defective degradation can cause pathology. For example, mutations that constitutively activate Gαs (as in some pituitary tumors) lead to uncontrolled cAMP production and excessive hormone secretion. Conversely, overactive phosphodiesterases can dampen signaling, as seen in some forms of heart failure where PDE activity is upregulated. Understanding the mechanisms of signal termination is essential for appreciating how cells maintain homeostasis and how pharmacological interventions can restore normal signaling.

Summary and Key Takeaways

Second messengers are the intracellular currency of signal transduction, translating extracellular cues into precise cellular responses. They provide amplification, spatial and temporal control, and integration of multiple signaling inputs. The major classes—cyclic nucleotides, lipid-derived messengers, calcium, and gases—each have distinct mechanisms of generation, action, and degradation. Their targets include protein kinases, ion channels, and transcription factors, enabling diverse physiological outcomes from metabolism to muscle contraction to cell proliferation.

The study of second messengers requires an appreciation of both the biochemistry of their synthesis and degradation and the cell biology of their compartmentalization. Modern techniques, including fluorescent biosensors and genetic manipulation, have revealed the remarkable complexity and specificity of these signaling systems. A thorough understanding of second messengers is fundamental to molecular biology, pharmacology, and medicine, as many drugs target components of these pathways.

Frequently Asked Questions

What is a second messenger?

A second messenger is a small intracellular molecule that is produced or released in response to an extracellular signal (the first messenger) and propagates that signal inside the cell by binding to specific effector proteins. Examples include cAMP, cGMP, IP3, DAG, calcium ions, and nitric oxide.

What are the main types of second messengers?

The main types are cyclic nucleotides (cAMP and cGMP), lipid-derived messengers (DAG, IP3, and PIP3), calcium ions (Ca²⁺), and gaseous messengers (NO, CO, and H₂S). Each class has distinct mechanisms of synthesis, subcellular localization, and target specificity.

What is the role of second messengers in cell signaling?

Second messengers relay and amplify signals from cell-surface receptors to intracellular targets. They activate protein kinases, modulate ion channels, and regulate transcription factors, thereby controlling processes such as metabolism, gene expression, cell proliferation, differentiation, and apoptosis.

How do second messengers amplify signals?

Amplification occurs because a single receptor activation can lead to the production of many second messenger molecules, each of which can activate multiple effector proteins. For example, one activated adenylyl cyclase can synthesize many cAMP molecules, and each cAMP-activated PKA can phosphorylate many substrate proteins, resulting in a cascade amplification of 10⁶-fold or more.

What is the difference between a first messenger and a second messenger?

A first messenger is an extracellular signaling molecule (hormone, neurotransmitter, or growth factor) that binds to a cell-surface receptor but does not enter the cell. A second messenger is produced inside the cell in response to first messenger-receptor interaction and carries the signal to intracellular targets.

Are all second messengers water-soluble?

No. DAG and PIP3 are lipid-derived and remain associated with membranes. Water-soluble messengers like cAMP, IP3, and calcium diffuse through the cytoplasm. This distinction is important for understanding the spatial restriction of signaling.

How are second messengers inactivated?

Second messengers are inactivated by enzymatic degradation (e.g., phosphodiesterases degrade cAMP and cGMP; phosphatases dephosphorylate IP3), by transport or pumping (e.g., calcium is pumped out of the cytosol by PMCA and SERCA), or by chemical reaction and diffusion (e.g., NO reacts with oxygen and has a short half-life). Signal termination is essential for proper cellular responses.

Key Takeaways

  • Second messengers are small intracellular molecules that relay and amplify signals from cell-surface receptors to intracellular effectors.
  • The major classes are cyclic nucleotides (cAMP, cGMP), lipid-derived messengers (DAG, IP3, PIP3), calcium ions, and gaseous messengers (NO, CO, H₂S).
  • Second messengers provide signal amplification, spatial and temporal regulation, and integration of multiple signaling inputs.
  • Synthesis is catalyzed by enzymes such as adenylyl cyclase, guanylyl cyclase, phospholipase C, and PI3K; degradation is mediated by phosphodiesterases, phosphatases, and calcium pumps.
  • Second messengers act primarily by activating protein kinases (PKA, PKG, PKC, CaMKs), regulating ion channels, and controlling transcription factor activity.
  • Physiological roles include glycogen metabolism (cAMP), muscle contraction (calcium), and cell proliferation (DAG/IP3).
  • Experimental methods include genetically encoded biosensors (GCaMP, FRET sensors), pharmacological tools (forskolin, thapsigargin, U73122), and genetic manipulation (knockouts, CRISPR, optogenetics).
  • Common misconceptions include confusing second messengers with hormones, assuming all are water-soluble, and overlooking the importance of signal termination.

Further Reading

  • Jenal U, Reinders A, Lori C. Cyclic di-GMP: second messenger extraordinaire. Nature reviews. Microbiology. 2017. PubMed 28163311
  • Pietrocola F et al. Acetyl coenzyme A: a central metabolite and second messenger. Cell metabolism. 2015. PubMed 26039447
  • Kato K et al. Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA. Annual review of biochemistry. 2017. PubMed 28399655
  • Gorelick FS. Second messenger systems and adaptation. Gut. 1987. PubMed 2826313
  • Su M et al. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): Synthesis, transmission, and degradation. Biochemical pharmacology. 2022. PubMed 35104477
  • Wu J et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science (New York, N.Y.). 2013. PubMed 23258412

Related Topics

Related Clinical & Scientific Guides